HR 2892
106th Congress
House
Health
Drug therapy
Drugs
Medicare
Social Welfare
Access to Innovation for Medicare Patients Act of 1999
Introduced: September 21, 1999
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 8, 1999
Referred to the Subcommittee on Health and Environment.
Sep 27, 1999
Referred to the Subcommittee on Health.
Sep 21, 1999
Referred to the Committee on Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 21, 1999
Introduced in House
Plain-English summary
Access to Innovation for Medicare Patients Act of 1999 - Amends title XVIII (Medicare) of the Social Security Act to provide for Medicare coverage of self-injected biologicals approved by the Food and Drug Administration that are prescribed for use in the treatment of the same disease or medical condition in lieu of a drug or biological which cannot be self-administered.
What's happening now
Referred to the Subcommittee on Health and Environment.
Committees of jurisdiction
4